A Phase 4 interventional study of OPTIVEtm Plus and No treatment in Contact Lens Related Dry Eye Syndrome, sponsored by Optometric Technology Group Ltd. Completed at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2013-09-27.
Sponsored by Optometric Technology Group Ltd · Phase 4, Interventional, and Treatment
The objectives of the investigation will be to assess the effect of the repeated usage of a new eye drop on the tear film characteristics of silicone hydrogel contact lens wearers with contact lens related comfort problems and to quantify any potential benefit.
1,292 studies on the registry are indexed under Dry Eye Syndromes; 191 are open to participants now.
This study's planned enrollment of 35 is below the median of 60 across 1,077 interventional studies indexed under Dry Eye Syndromes.
Browse Dry Eye Syndromes studies →Optometric Technology Group Ltd is the lead sponsor of 2 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion criteria:
One month of contact lens wear with use of the Test study eye drops
Device: OPTIVEtm Plus
One month of contact lens wear with no eye drop use
Procedure: No treatment
One month of contact lens wear with use of the Control study eye drops
Device: Blink Contacts® Eye Drops
1 drop in each eye four times a day for a period of 30 (± 3) days
One month of contact lens wear with no eye drop use
1 drop in each eye four times a day for a period of 30 (± 3) days
Also known as: Blink Contacts®
Tear Break up Time
Time frame: 30 days
Conjunctival staining measurement
Time frame: 30 days
Tear film evaporation rate
Time frame: 30 days
Ocular Surface Disease Index questionnaire
Time frame: 30 days
Comfort, vision and ocular symptoms questionnaire
Time frame: 30 days
Post wear contact lens deposition and lipid uptake assessment
Time frame: 30 days
This study is completed, as verified in Sep 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Optometric Technology Group Ltd